Geoff Catalano

Geoff Catalano has a diverse work experience in the field of medical and scientific affairs. Geoff is currently the VP, Medical Director, Medical Strategy and Scientific Affairs at BGB Group since August 2020. Prior to this, they served as a Senior Medical Director and Medical Director at BGB Group as well. Geoff also worked as a Medical Director at BIONYC and as an Associate Medical Director and Medical Writer at BGB NY.

Before joining the BGB Group, Geoff worked as an Adjunct Professor at Manhattan College where they taught immunology to undergraduate students. Geoff designed the curriculum, exams, and integrated current topics and research into their teaching.

Geoff started their career as a Graduate Research Assistant at Columbia University Medical Center, where they studied Fc Receptors and their role on dendritic cells. This research was relevant for autoimmune diseases and antibody-based cancer therapies.

Prior to their role at Columbia University, Geoff worked as a Research Technician at Roswell Park Cancer Institute. Geoff collaborated with Thomas B Tomasi, MD, PhD, in the Immunology Department, where they wrote standard operating protocols for new real-time, quantitative PCR technology. Geoff also contributed figures, helped write methods sections, and edited submissions for publications and grants.

Overall, Geoff Catalano has extensive experience in medical and scientific roles, making him a valuable asset in the field.

Geoff Catalano obtained a Ph.D. degree in Microbiology & Immunology from Columbia University Vagelos College of Physicians and Surgeons, which took place between the years 2002 to 2010. Prior to their Ph.D., Geoff completed their undergraduate studies at the University at Buffalo, where they earned a Bachelor of Science (B.S.) degree in Chemical Engineering with a minor in Biotechnology. The specific dates of their undergraduate education are not provided.